Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Investments (2021 - 2023)

Historic Long-Term Investments for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $27.0 million.

  • ADC Therapeutics' Long-Term Investments fell 2219.28% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 2219.28%. This contributed to the annual value of $7.6 million for FY2022, which is 1836202.35% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Long-Term Investments is $27.0 million, which was down 2219.28% from $28.3 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Long-Term Investments high stood at $47.4 million for Q1 2021, and its period low was $41236.0 during Q4 2021.
  • For the 3-year period, ADC Therapeutics' Long-Term Investments averaged around $30.9 million, with its median value being $34.7 million (2022).
  • In the last 5 years, ADC Therapeutics' Long-Term Investments soared by 1836202.35% in 2022 and then crashed by 2375.43% in 2023.
  • Over the past 3 years, ADC Therapeutics' Long-Term Investments (Quarter) stood at $41236.0 in 2021, then soared by 18362.02% to $7.6 million in 2022, then skyrocketed by 254.51% to $27.0 million in 2023.
  • Its last three reported values are $27.0 million in Q3 2023, $28.3 million for Q2 2023, and $29.5 million during Q1 2023.